Northpond Ventures
Venture capitalBethesda · Seed · 22 people tracked
Investment thesis
NPV targets breakthrough innovations at the intersection of science and technology. The firm supports entrepreneurs with bold visions and commitments full participation alongside portfolio partners. The investment thesis emphasizes discovering the next generation of transformative discoveries with potential to drive meaningful change.
Source: firm website, verified Jul 21, 2026.
Team · 22 people
from the firm's website
What they invest in
from 9 of 9 portfolio companiesAI & Machine Learning ×8Biotech ×7Medical Devices ×5Healthtech ×4Digital Health ×2SaaS ×2Cloud Computing ×1Data & Infrastructure ×1
HQs:United States×5
Investments · 9 tracked
founders shown can be your intro pathInflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings. The company's diagnostic platform serves healthcare providers treating acutely ill patients, with applications extending to emerging infectious diseases, autoimmune conditions, and transplant rejection.
AI & Machine LearningBiotechHealthtechMedical Devices
Tim Sweeney(Co-Founder and CEO)Purvesh Khatri(Co-Founder and Chief Scientist)
Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The company's tests enable physicians and patients to measure disease progression and treatment response through blood draws rather than traditional clinical assessments.
AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US
William Hagstrom(Founder and Chairman)Doug Biehn(President and CEO)
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)Jiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechMedical Devices
Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.
AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US
Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
AI & Machine LearningDigital HealthHealthtech
Maya R. Said(Founder and CEO)
Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics. The platform serves life sciences companies and other science-based industries operating in regulated environments.
AI & Machine LearningBiotechData & InfrastructureSaaS
Ajit Nagral(CEO & Chairman)
Vizgen provides spatial multiomics platforms that enable researchers, clinicians, and biopharma teams to map and analyze RNA and protein molecules at single-cell resolution for disease understanding and precision medicine applications. The company merged with Ultivue in 2024 to combine spatial genomics and multiplex proteomic detection capabilities.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Uptime Health provides operational tools and preventive maintenance plans to healthcare practices to reduce downtime and ensure regulatory compliance.
Enterprise SoftwareHealthtechSaaSBoston, US
Frequently asked questions
- What stage does Northpond Ventures invest at?
- Northpond Ventures invests at the Seed stage.
- What sectors does Northpond Ventures focus on?
- Northpond Ventures focuses on AI & Machine Learning, Biotech, Cleantech, Deep Tech, Energy.
- Where is Northpond Ventures located?
- Northpond Ventures is headquartered in Bethesda, US.
Images
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
A venture capital firm based in Oklahoma City that invests in seed-stage frontier technology companies serving large legacy industries in the U.S. Midcontinent region. Cortado partners with experienced technical founders and industry leaders to commercialize disruptive innovations in energy, healthcare, manufacturing, and mobility.
Creative Ventures is a deep tech venture capital firm investing in early-stage companies addressing critical global challenges across climate, industry, health, and computing. The firm focuses on AI-enablers, advanced semiconductors, AI applications, and biodata technologies with real-world impact.